NIH-funded research R01 grant

What causes Coats plus at the molecular level

Official title: Molecular Basis of Coats Plus Disease

Funded at Rosalind Franklin Univ of Medicine & Sci · NIH-11245734 · Data updated 2026-11-12

Researchers are looking at how problems in a DNA-protecting protein complex lead to the DNA-copying errors that cause Coats plus in affected people.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRosalind Franklin Univ of Medicine & Sci
NIH-funded
Lab location1 site (North Chicago, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2026
Funding year2026
Award (this year)$400,847
NIH project number5R01GM146376-05
Project IDNIH-11245734 on NIH RePORTER

Who could benefit from this research

Could help

People with genetically confirmed Coats plus (pathogenic CTC1, STN1, or TEN1 variants) or family members interested in contributing samples or clinical information would be most relevant for related participation.

Less likely to help

People without Coats plus or without CST mutations and anyone seeking immediate clinical treatments are unlikely to receive direct benefit from this basic laboratory research.

What this research studies

You may hear that scientists are focusing on the CST protein complex (CTC1/STN1/TEN1) that normally protects DNA during cell division and keeps genomes stable. They will examine how cells respond when DNA copying stalls, including processes like fork reversal, bypass synthesis, repriming, and firing backup start sites, and how those actions are controlled. The team will map the signaling and protein recruitment at stalled replication forks to see what goes wrong when CST is defective. Most work will be done in lab-grown human cells and model systems to trace molecular steps that lead to the organ problems seen in Coats plus.

Why it matters

Potential benefit: If successful, this work could point to targets or strategies to protect DNA replication and eventually lead to therapies that reduce tissue damage in Coats plus.

How similar studies have gone: Previous lab studies have clarified parts of CST function and genome-stability pathways, but turning that knowledge into treatments for Coats plus remains largely untested.

Where this research is happening

  • Rosalind Franklin Univ of Medicine & Sci
    North Chicago, United States
    Active

Researchers

  • Principal investigator: Chai, Weihang — Rosalind Franklin Univ of Medicine & Sci
  • Study coordinator: Chai, Weihang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.